Is chronic inhibition of phosphodiesterase type 5 cardioprotective and safe? A meta-analysis of randomized controlled trials, BMC Medicine
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Left ventricular diastolic dysfunction is associated with cerebral infarction in young hypertensive patients: A retrospective case‑control study
The Fontan Circulation: From Ideal to Failing Hemodynamics and Drug Therapies for Optimization - Canadian Journal of Cardiology
Cardiac System during the Aging Process
JAMA-PDE5i in heart failure
Phosphodiesterase Type 5 Inhibitors for Pulmonary Arterial Hypertension
Effects of phosphodiesterase type 5 inhibitors on endothelial function and cardiovascular autonomic nerve function in men
Pharmaceuticals, Free Full-Text